Systematic Review and Meta-Analysis: Placebo Response in Randomized Controlled Trials of Tourette’s Disorder Medications
- 3 November 2024
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 64 (5) , 577-592
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
- Patterson Foundation
- Biohaven Pharmaceuticals
- National Institutes of Health
This publication has 81 references indexed in Scilit:
- Association of Single-blind Placebo Run-in Periods With the Placebo Response in Randomized Clinical Trials of AntidepressantsJAMA Psychiatry, 2021
- Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette SyndromeJAMA Network Open, 2021
- Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJAMA Network Open, 2021
- Systematic review of severity scales and screening instruments for tics: Critique and recommendationsMovement Disorders, 2017
- Impact of placebo assignment in clinical trials of tic disordersMovement Disorders, 2013
- A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndromeMovement Disorders, 2012
- A double blind randomized placebo control trial of levetiracetam in tourette syndromeMovement Disorders, 2007
- A Double-blind Comparison of Desipramine and Placebo in Children and Adolescents With Chronic Tic Disorder and Comorbid Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry, 2002
- Clonidine Treatment of Gilles de la Tourette's SyndromeArchives of General Psychiatry, 1991
- Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's SyndromeArchives of General Psychiatry, 1989